FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA 2nd Complete Response on Parkinsons Drug

FDA sends Supernus Pharmaceuticals a second complete response letter on its NDA resubmission for the companys apomorphine infusion device (SPN-830) fo...

latest-news-card-1
Federal Register

Nominations Sought for Patient Engagement Panel

Federal Register notice: FDA requests nominations for voting members, excluding consumer and industry representatives, to serve on CDRHs Patient Engag...

latest-news-card-1
Federal Register

Meeting on User Fee Program Financials

Federal Register notice: FDA announces a 6/6 public meeting entitled Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Bios...

latest-news-card-1
Federal Register

24 Drugs Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that 24 listed drug products were not withdrawn from sale for reasons of safety or effectiveness.

latest-news-card-1
Medical Devices

De Novo for Antibacterial Coated Implants

FDA grants Onkos Surgical a de novo marketing authorization for its novel antibacterial coated implants.

latest-news-card-1
Federal Register

Shuffert Debarred for 5 Years

Federal Register notice: FDA issues an order to debar for five years Robert Lance Shuffert from importing or offering for import any drug into the U.S...

latest-news-card-1
Human Drugs

Abecma Expanded Approval for Multiple Myeloma

FDA approves a Bristol Myers Squibb and 2Seventy Bio supplemental BLA for Abecma (idecabtagene vicleucel; ide-cel) for treating certain adult patients...

latest-news-card-1
Medical Devices

Honeywell Recalls Eyewash Cartridge

Honeywell Safety Products recalls its Fendall 2000 Non-Sterile Eyewash Cartridge for the Fendall 2000 Eyewash Station due to GMP concerns.

latest-news-card-1
Human Drugs

Accelerated Approval for Enhertu in Solid Tumors

FDA grants Daiichi Sankyo an accelerated approval for Enhertu (fam-trastuzumab deruxtecan-nxki) for treating certain adult patients with unresectable ...

latest-news-card-1
Human Drugs

Jubilant Generics Cited Over GMPs

FDA issues Jubilant Generics a four-observation Form FDA-483 after inspecting the firms India facility in February.